Nektar Therapeutics (NKTR) EBIT Margin Growth (5y) (2015 - 2026)
Powered by 
Analysis
Nektar Therapeutics (NKTR) EBIT Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Nektar Therapeutics | 2.45 Bn | 1.77 Bn | 3.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,893.00 |
| Mar 31, 2026 | 10,302.00 |
| Dec 31, 2025 | 34,505.00 |
| Sep 30, 2025 | 7,449.00 |
| Jun 30, 2025 | -16,512.00 |
| Mar 31, 2025 | -16,153.00 |
| Dec 31, 2024 | 37,296.00 |
| Sep 30, 2024 | 19,557.00 |
| Jun 30, 2024 | 26,406.00 |
| Mar 31, 2024 | 26,392.00 |
| Dec 31, 2023 | 11,153.00 |
| Sep 30, 2023 | 16,947.00 |
| Jun 30, 2023 | -33,635.00 |
| Mar 31, 2023 | -39,568.00 |
| Dec 31, 2022 | -21,307.00 |
| Sep 30, 2022 | -27,528.00 |
| Jun 30, 2022 | -56,161.00 |
| Mar 31, 2022 | -24,944.00 |
| Dec 31, 2021 | -36,564.00 |
| Sep 30, 2021 | -36,528.00 |